PMID: 16510050Mar 3, 2006Paper

Optimal low-density lipoprotein levels: evidence from epidemiology and clinical trials

Current Atherosclerosis Reports
Josh Todd, John A Farmer

Abstract

Aggressive lipid lowering was initially controversial due to evidence from epidemiologic studies that implied an increase in total mortality with low cholesterol levels combined with equivocal results from early trials utilizing bile acid resins or fibric acid derivatives. The advent of statin therapy allowed significant reductions of circulating lipid levels and clearly reduced cardiovascular morbidity and mortality. Additionally, in adequately powered trials, total mortality was also reduced. The optimal level of circulating low-density lipoprotein (LDL) has not been definitely established. However, recent clinical trials with aggressive lipid goals have established that LDL cholesterol can be significantly lowered below 100 mg/dL with improvement in both surrogate measurements and hard clinical endpoints. Ongoing clinical trials have been initiated that will determine the optimal level of LDL cholesterol that will insure cardiovascular benefits and establish the risk-benefit relationship of aggressive pharmacologic lowering of circulating lipid levels.

References

Nov 28, 1986·JAMA : the Journal of the American Medical Association·W P CastelliW B Kannel
Dec 6, 2000·Journal of Psychiatric Research·B A GolombS Mednick
Mar 5, 2004·JAMA : the Journal of the American Medical Association·Steven E NissenUNKNOWN REVERSAL Investigators
Mar 10, 2004·The New England Journal of Medicine·Christopher P CannonUNKNOWN Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators
Sep 1, 2004·JAMA : the Journal of the American Medical Association·James A de LemosUNKNOWN Investigators
Nov 3, 2004·Journal of the American College of Cardiology·Michael J KorenUNKNOWN ALLIANCE Investigators
Mar 10, 2005·The New England Journal of Medicine·John C LaRosaUNKNOWN Treating to New Targets (TNT) Investigators
Oct 18, 2005·Journal of the American College of Cardiology·Stephen D WiviottUNKNOWN PROVE IT-TIMI 22 Investigators

❮ Previous
Next ❯

Citations

Sep 5, 2007·Cell Metabolism·Yaoyu ChenXiaosong Wang
Mar 22, 2020·International Journal of Molecular Sciences·Anastasia V PoznyakAlexander N Orekhov

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.